5 Booming Biotech Stocks to Buy


by Kiplinger

Kiplinger— You could say biotechnology companies' shares were merely "interrupted" this year. Biotech stocks, as measured by the iShares Nasdaq Biotechnology ETF (IBB), started to rally furiously in the back half of 2019. The COVID-sparked market downturn knocked them down, but they've returned to outperformance and are now up 15% year-to-date. The party likely isn't over, either. New markets in areas such as anti-aging therapies and gene editing could be worth billions of dollars over the coming decade....

www.bloomberg.com—NVIDIA in advanced talks to buy ARM. To continue, please click the box below to let us know you're not a robot.

www.bloomberg.com—Biden Campaign Bans Staff From Trading Stocks Without Approval. To continue, please click the box below to let us know you're not a robot.

www.bloomberg.com—Tencent Loses $30 Billion as WeChat Ban Rocks China Stocks, Yuan. To continue, please click the box below to let us know you're not a robot.